Survival benefits and trends in use of adjuvant therapy among elderly stage II and III rectal cancer patients in the general population
Open Access
- 1 February 2008
- Vol. 112 (4), 789-799
- https://doi.org/10.1002/cncr.23244
Abstract
BACKGROUND This study examined elderly stage II and III rectal cancer patients' adjuvant chemoradiation therapy adherence, trends in adherence over time, and the relation of levels of adherence to mortality. METHODS The authors studied 2886 stage II and III rectal cancer patients who had surgical resection and who appeared in 1992–1999 linked SEER‐Medicare claims data. The authors compared measures of adjuvant radiation and chemotherapy receipt and completion between stage II and III patients. Adjusted risk of cancer‐related 5‐year mortality was calculated by multivariate logistic regression for different levels of chemoradiation adherence among stage II and III patients. RESULTS Of the 2886 patients, 45.4% received both adjuvant radiation and chemotherapy. Stage III patients were more likely to receive chemoradiation than stage II patients. The receipt of chemoradiation by stage II patients increased significantly from 1992 to 1999. Stage III patients were more likely to complete radiation therapy (96.6%), chemotherapy (68.2%), and both modalities (67.5%) than stage II patients (91.5%, 49.8%, 47.6%, respectively). Only a complete course of both radiation and chemotherapy for both stage II (relative risk [RR] 0.74; 95% CI, 0.54, 0.97) and III (RR 0.80; 95% CI, 0.65, 0.96) decreased the adjusted 5‐year cancer mortality risk compared with counterparts with no adjuvant therapy. CONCLUSIONS Even though stage II rectal cancer patients were less likely than stage III patients to receive and complete adjuvant chemoradiation, both patient groups in the general population had lower cancer‐related mortality if they completed chemoradiation. These patients deserve support and encouragement to complete treatment. Cancer 2008. © 2008 American Cancer Society.Keywords
This publication has 48 references indexed in Scilit:
- Completion of Therapy by Medicare Patients With Stage III Colon CancerJNCI Journal of the National Cancer Institute, 2006
- Re: Colon Cancer Survival Rates With the New American Joint Committee on Cancer Sixth Edition StagingJNCI Journal of the National Cancer Institute, 2005
- Recurrence and survival after mesorectal excision for rectal cancerBritish Journal of Surgery, 2003
- Studying Radiation Therapy Using SEER-Medicare-Linked DataMedical Care, 2002
- Rectal CancerArchives of Surgery, 1998
- High-dose preoperative radiation for cancer of the rectum: Impact of radiation dose on patterns of failure and survivalInternational Journal of Radiation Oncology*Biology*Physics, 1993
- Presentation adapting a clinical comorbidity index for use with ICD-9-CM administrative data: Differing perspectivesJournal of Clinical Epidemiology, 1993
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987
- Survival after Postoperative Combination Treatment of Rectal CancerNew England Journal of Medicine, 1986
- Prolongation of the Disease-Free Interval in Surgically Treated Rectal CarcinomaNew England Journal of Medicine, 1985